Analysis of the MCL-1 gene in Chinese women with idiopathic premature ovarian insufficiency

Abstract Objective Animal studies have demonstrated that myeloid cell leukemia-1 (Mcl-1) gene deficiency leads to premature ovarian failure and decreased reproductive ability in mice. This study investigated the relationship between MCL-1 gene variation and idiopathic premature ovarian insufficiency (POI) in Chinese women. Methods A total of 200 idiopathic POI patients and 100 healthy controls were recruited for this study, and peripheral blood was collected. First, genomic DNA was extracted from peripheral leukocytes. Then, the entire coding region and splice sites of the MCL-1 gene were amplified by polymerase chain reaction. Chi-squared tests were used to compare the genotype distribution and allele frequency of single nucleotide polymorphisms between the POI and control groups. Results Three mutations of the MCL-1 gene (c.–36C > T, c.–131C > T and c.78C > T) were identified. After data analysis, c.–36C > T and c.–131C > T in the 5′-untranslated region were both found in the POI group and the control group. No difference was found in the genotype distribution or allelic frequency of either variant between the POI group and the control group (p > 0.05). The synonymous variant (c.78C > T) in exon 1 was discovered in only one of the control subjects and did not result in a change in amino acid sequence (p.Gly26Gly). Conclusion MCL-1 gene mutation may not be associated with idiopathic POI in Chinese women.

[1]  Chunyan Liu,et al.  Mutation of MDM2 gene in Chinese Han women with idiopathic premature ovarian insufficiency. , 2020, International journal of clinical and experimental pathology.

[2]  L. Jin,et al.  Rare variants in FANCA induce premature ovarian insufficiency , 2019, Human Genetics.

[3]  K. Chrzanowska,et al.  A case of premature ovarian insufficiency in Nijmegen breakage syndrome patient and review of literature. From gene mutation to clinical management , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  G. Lin,et al.  DMC1 mutation that causes human non-obstructive azoospermia and premature ovarian insufficiency identified by whole-exome sequencing , 2018, Journal of Medical Genetics.

[5]  C. Yin,et al.  Hydrogen-rich Water Exerting a Protective Effect on Ovarian Reserve Function in a Mouse Model of Immune Premature Ovarian Failure Induced by Zona Pellucida 3 , 2016, Chinese medical journal.

[6]  R. Cífková,et al.  ESHRE Guideline: management of women with premature ovarian insufficiency. , 2016, Human Reproduction.

[7]  Zi-jiang Chen,et al.  Genetics of primary ovarian insufficiency: new developments and opportunities , 2015, Human reproduction update.

[8]  J. Opferman,et al.  Mcl-1 is a key regulator of the ovarian reserve , 2015, Cell Death and Disease.

[9]  X. Shu,et al.  Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese Women , 2014, PloS one.

[10]  L. Nelson,et al.  A new approach to primary ovarian insufficiency. , 2012, Obstetrics and gynecology clinics of North America.

[11]  Yan Guo-zhe Research Progress of Premature Ovarian Failure Diagnosed by Transvaginal Color Doppler Ultrasound , 2012 .

[12]  F. Matsuda,et al.  Role of cell-death ligand-receptor system of granulosa cells in selective follicular atresia in porcine ovary. , 2011, The Journal of reproduction and development.

[13]  A. Shelling Premature ovarian failure. , 2010, Reproduction.

[14]  L. Nelson Clinical practice. Primary ovarian insufficiency. , 2009, The New England journal of medicine.

[15]  N. Panay Management of Premenstrual Syndrome , 2009, Journal of Family Planning and Reproductive Health Care.

[16]  P. Furth,et al.  BAX is involved in regulating follicular growth, but is dispensable for follicle atresia in adult mouse ovaries. , 2007, Reproduction.

[17]  Mahmoud R Hussein,et al.  Apoptosis in the ovary: molecular mechanisms. , 2005, Human reproduction update.

[18]  G. Wood,et al.  Apoptosis and melanoma: molecular mechanisms , 2003, The Journal of pathology.

[19]  R. Anderson,et al.  Developmental changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and early folliculogenesis. , 2002, The Journal of clinical endocrinology and metabolism.

[20]  T. Simonart,et al.  Interleukin-1 beta increases the BCL-2/BAX ratio in Kaposi's sarcoma cells. , 2002, Cytokine.

[21]  E. Yeh,et al.  Regulation of Apoptosis and Cell Cycle Progression by MCL1 , 2000, The Journal of Biological Chemistry.

[22]  J. Bae,et al.  MCL-1S, a Splicing Variant of the Antiapoptotic BCL-2 Family Member MCL-1, Encodes a Proapoptotic Protein Possessing Only the BH3 Domain* , 2000, The Journal of Biological Chemistry.

[23]  K. Roth,et al.  Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.

[24]  C. Prinz,et al.  IL-1beta-induced apoptosis in rat gastric enterochromaffin-like cells is mediated by iNOS, NF-kappaB, and Bax protein. , 2000, Gastroenterology.

[25]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[26]  S. Korsmeyer,et al.  Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency , 1999, Nature Genetics.